Axlab Revenue and Competitors
Employee Data
- Axlab has 45 Employees.
- Axlab grew their employee count by 55% last year.
Axlab's People
Name | Title | Email/Phone |
---|---|---|
1 | Lager- & logistikmedarbejder | Reveal Email/Phone |
2 | Product Specialist | Reveal Email/Phone |
3 | Product Specialist | Reveal Email/Phone |
4 | Financial Controller | Reveal Email/Phone |
5 | Event & Marketing Platform Coordinator | Reveal Email/Phone |
6 | Office Coordinator | Reveal Email/Phone |
7 | Applikationsspecialist | Reveal Email/Phone |
8 | Product Specialist | Reveal Email/Phone |
Axlab Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 60 | 43% | N/A | N/A |
#2 | N/A | 67 | 109% | N/A | N/A |
#3 | N/A | 49 | 32% | N/A | N/A |
#4 | N/A | 45 | 55% | N/A | N/A |
What Is Axlab?
Axlab A/S is a Danish-owned company that since 1993 has supplied advanced equipment to pathology departments at hospitals and laboratories. Today, we deliver solutions throughout Europe and the United States. We are headquartered in Vedbæk, near Copenhagen and have a subsidiary in Sweden.\n\nThe ability to understand the everyday life of the individual bioanalyst and pathologist is absolutely essential for Axlab. We have our roots in the world of the laboratory and visit the pathology departments of the hospitals as often as possible to experience the challenges of everyday life up close.\n\nAnd it is with this valuable knowledge as inspiration that we deliver the advanced technological solutions that are not only crucial for the laboratory’s efficiency but also ensure an optimal working environment and the highest possible quality in the analysis work. For the benefit of both staff and patients.
keywords:N/AN/A
Total Funding
45
Number of Employees
N/A
Revenue (est)
55%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 102 | 36% | N/A |
#2 | $22.7M | 108 | -3% | N/A |
#3 | $75M | 617 | 5% | N/A |